This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Victor Shashilov: Innovator in Cell Culture Technology
Introduction
Victor Shashilov is a notable inventor based in Castleton, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell culture technology. His innovative methods have the potential to enhance the production of recombinant proteins, which are crucial for various applications in medicine and research.
Latest Patents
Victor Shashilov holds a patent for "Methods of improving protein titer in cell culture." This patent describes methods for improving recombinant protein titer and cell titer in cell culture using media that have reduced impurities. The cell culture media, which includes a HEPES buffer, is designed to minimize HEPES-related impurities. The methods and media outlined in the patent aim to improve protein titer, cell growth, and viable cell density, thereby enhancing the efficiency of protein production.
Career Highlights
Victor Shashilov is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in biotechnology to advance the company's research and development efforts. His work focuses on optimizing cell culture processes, which are essential for the production of therapeutic proteins.
Collaborations
Victor collaborates with talented colleagues, including Reginald Smith and Sarah Nicoletti, who contribute to the innovative environment at Regeneron Pharmaceuticals, Inc. Their combined efforts foster advancements in biotechnology and improve the efficiency of protein production.
Conclusion
Victor Shashilov's contributions to cell culture technology exemplify the impact of innovation in biotechnology. His patented methods for improving protein titer are a testament to his dedication to advancing scientific research and development.
